Management of anaphylaxis due to COVID‐19 vaccines in the elderly

Male COVID-19 vaccines older (adults GUIDELINES 0302 clinical medicine [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases Medicine and Health Sciences info:eu-repo/classification/ddc/618 Immunology and Allergy [SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases [SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology MESH: Aged RISK Vaccines [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases people) EPINEPHRINE General medicine, internal medicine and other clinical medicine [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system 3. Good health [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases COVID -19 vaccines [SDV.MP.PAR] Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology older (adults/people) Risk COVID-19 Vaccines Epinephrine MESH: Covid-19 MESH: Epinephrine Anaphylaxis / etiology Immunology adrenaline; anaphylaxis; COVID-19 vaccines; older (adults/people); Aged; COVID-19 Vaccines; Epinephrine; Humans; Male; SARS-CoV-2; Anaphylaxis; COVID-19 Guidelines Adrenaline 03 medical and health sciences [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system Anaphylaxis/etiology anaphylaxis Humans MESH: SARS-CoV-2 [SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology Anaphylaxis Older - Adults/people Aged MESH: Humans adrenaline SARS-CoV-2 adrenaline, anaphylaxis, COVID-19 vaccines, older (adults/people) COVID-19 [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology Anaphylaxis / prevention & control 300 MESH: Male MESH: Anaphylaxis Older [SDV.MP.BAC] Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology MESH: Covid-19 vaccines Older (adults/people)
DOI: 10.1111/all.14838 Publication Date: 2021-04-03T02:20:55Z
AUTHORS (149)
ABSTRACT
Older adults, especially men and/or those with diabetes, hypertension, obesity, are prone to severe COVID-19. In some countries, older particularly residing in nursing homes, have been prioritized receive COVID-19 vaccines due high risk of death. very rare instances, the can induce anaphylaxis, and management anaphylaxis people should be considered carefully. An ARIA-EAACI-EuGMS (Allergic Rhinitis its Impact on Asthma, European Academy Allergy Clinical Immunology, Geriatric Medicine Society) Working Group has proposed recommendations for adults receiving vaccines. Anaphylaxis is extremely (from 1 per 100,000 5 million injections). Symptoms similar younger but they tend more patients. Adrenaline mainstay treatment readily available. A flowchart manage
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (52)
CITATIONS (19)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....